Press Releases 2022


Provides Updates On Telehospital Purchase; $2.5 Million Private Placement

Toronto, ON – March 2, 2022 – LevelJump Healthcare Corp. (TSXV: JUMP) (OTCQB: JMPHF) (FSE: 75J) ("LevelJump" or the "Company"), a Canadian leader in B2B telehealth solutions, is pleased to announce the following corporate updates:

Telehospital Purchase
Further to its news releases of October 1, 2021, and November 16, 2021, Leveljump announces that closing of the Telehospital Purchase, which had originally been scheduled for the end of January 2022 and then extended to February 28, 2022, has now been further extended to April 30, 2022 to allow additional time to complete required due diligence and to ensure that sufficient financing is in place to enable the Company to meet its funding obligations. TSX Venture Exchange (the “Exchange”) has also conditionally approved the issuance of 4,000,000 common shares of the Company which form part of the consideration payable for the acquisition (see the Company’s news release dated November 16, 2021). A further update will be provided as and when closing occurs.

Extension of Closing of $2.5 Million Private Placement
The Company wishes to an announce that, further to its news release of January 21, 2022, it has extended the closing date on its previously announced non brokered private placement of 16,666,667 units at a price of $0.15 per unit for gross proceeds of $2.5 million. Closing, originally scheduled for the end of January has been extended to March 31, 2022 and is subject to Exchange consent. Each unit consists of one common share and one common share purchase warrant, each warrant entitling the holder to acquire one additional common share at a price of $0.20 for a period of two years after closing. Proceeds from this offering will be used for acquisitions and for general working capital purposes.

About LevelJump Healthcare
Leveljump Healthcare Corp., (TSXV: JUMP) (OTCQB: JMPHF) (FSE: 75J) is a healthcare company with a focus on profitable telehealth solutions as well as primary care services in radiology. The Company’s subsidiary, CTS, provides off-site radiology readings for hospital emergency rooms and is a leader in the teleradiology space in Ontario. As part of our growth strategy, we are acquiring healthcare companies that have strong revenue and cash flow, with room for organic growth.


Mitchell Geisler, Chief Executive Officer
(833) 840-2020

This news release contains "forward-looking information" within the meaning of applicable securities laws relating to the Company's business plans and the outlook of the Company's industry. Although the Company believes, in light of the experience of its officers and directors, current conditions and expected future developments and other factors that have been considered appropriate, that the expectations reflected in this forward-looking information are reasonable, undue reliance should not be placed on them because the Company can give no assurance that they will prove to be correct. Actual results and developments may differ materially from those contemplated by these statements. The statements in this press release are made as of the date of this release and the Company assumes no responsibility to update them or revise them to reflect new events or circumstances other than as required by applicable securities laws. The Company undertakes no obligation to comment on analyses, expectations or statements made by third parties in respect of the Company, Canadian Teleradiology Services, Inc., their securities, or their respective financial or operating results (as applicable).

Neither the Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Exchange) accepts responsibility for the adequacy or accuracy of this release.

The securities being offered have not been, and will not be, registered under the United States Securities Act of 1933, as amended (the "U.S. Securities Act") or any U.S. state securities laws, and may not be offered or sold in the United States or to, or for the account or benefit of, United States persons absent registration or an applicable exemption from the registration requirements of the U.S. Securities Act and applicable U.S. state securities laws. This press release does not constitute an offer to sell or the solicitation of an offer to buy securities in the United States, nor in any other jurisdiction.